The Michael Smith Foundation of Health Research and Arthritis Research Canada have partnered to co-develop and host a series of monthly expert-led, beginner-level KT training webinars with the goal of developing a sustainable resource for researchers and trainees to learn knowledge and skills that will enable them to develop KT practice in their work.
Topic: Citizen as KT Agent: Keeping the government informed about research
Speaker: Cheryl Koehn, Founder and President of Arthritis Consumer Experts
Date and time: Friday, April 28, 2017 from 12:00 pm-1:00 pm PDT
Register: Please click here to register for this free webinar
The Canadian Institute for the Relief of Pain and Disability (CIRPD) regularly hosts free webinars. The next one, conducted in partnership with Pain BC and the Canadian Pain Coalition, will be on Wednesday, December 9 at 9:30 am PST (12:30 pm EST). The Digital Health Technologies: Improving Outcomes in Paediatric Chronic Pain webinar will look at how the use of digital health technologies has facilitated access to appropriate and timely care. Continue reading
Aujourd’hui, les produits biologiques ultérieurs (PBU) sont au cœur de l’actualité en soins de santé. Une nouvelle catégorie de médicaments fait son entrée sur le marché canadien et les consommateurs et patients atteints de formes autoimmunes d’arthrite et autres maladies affectant le système immunitaire doivent absolument en apprendre plus sur le sujet, auprès de sources d’information fiables.
Le comité ACE (Arthritis Consumer Experts) et le groupe de programmes d’éducation JointHealth™ sont ravis de vous offrir cette présentation des faits sur les PBU, par un éminent rhumatologue:
Dr Michel Zummer
Chef, Rhumatologie, CH Maisonneuve-Rosemont
Professeur agrégé, Université de Montréal
Pour vous inscrire au webinaire « Faits PBU », veuillez remplir le formulaire. Remplissez tous les champs marqués d’un * et cliquez sur « soumettre ».
Vous recevrez deux courriels de rappel à mesure que la date de diffusion du webinaire approche.
Merci de votre inscription au webinaire ACE sur les « Faits PBU ».
Subsequent entry biologics (SEBs) are a “hot topic” in health care today. They are a new class of medications entering the Canadian marketplace and consumers and patients living with autoimmune forms of arthritis and other diseases affecting the immune system need to learn about them from credible sources.
Arthritis Consumer Experts and the JointHealth™ family of education programs is pleased to offer you the latest facts on SEBs from leading patient educator and advocate:
Ms. Cheryl Koehn
Founder and President, Arthritis Consumer Experts
To register for the “SEB Facts” webinar, please complete the form. Please complete all fields marked * and click “submit”.
You will receive 2 reminder emails as the broadcast date nears.
Thank you for registering for Arthritis Consumer Experts’ “SEB facts” Webinar.
Cheryl Koehn, President of Arthritis Consumer Experts, will be presenting in a free webinar on subsequent entry biologics today from 7pm-8pm EST. The webinar is hosted by the Canadian Breast Cancer Network and is the first webinar of 2015 on Subsequent Entry Biologics (SEBs) and how these drugs impact breast cancer treatment.
The network is hosting the webinar in anticipation of SEBs being introduced into breast cancer treatment in about five years when Herceptin comes off patent. Because SEBs have been part of the arthritis community for a number of years now, Cheryl Koehn will explain how the arthritis community has dealt with SEBs and what the Canadian Breast Cancer Network can expect once SEBs for breast cancer enter the marketplace.
Below are the learning outcomes of the webinar:
- What are Subsequent Entry Biologics, or SEBs?
- Why should you care about SEBs?
- What breast cancer specific biologics will be affected?
- How did the arthritis community prepare for their arrival into the marketplace?
- What can you do to stay abreast of SEB developments in breast cancer?
How to register:
To register for this FREE webinar, please CLICK HERE.
*Once you’ve registered, you should receive a confirmation email within 30 minutes. If you do not receive a confirmation email, please contact Rebecca at email@example.com.
Content for this webinar was made possible through an unrestricted grant from Hoffmann-La Roche Limited.